U.S. OKs Lupin generic of Pfizer nerve pain drug

Thu Jul 5, 2012 1:40pm EDT

Related Topics

(Reuters) - India's Lupin Ltd said it won U.S. approval for a generic version of Pfizer Inc's big-selling Lyrica nerve pain treatment.

A spokesman for Lupin said it has not yet launched its version of Lyrica, which is also known as pregabalin.

Lyrica tallied U.S. sales of about $1.8 billion for the year ended in March, Lupin said, citing data from IMS Health Inc.

(Reporting by Lewis Krauskopf; Editing by Gerald E. McCormick)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Retirement Road Map